Atropine Sulfate Injection, Solution
Product Images NDC 16729-512

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 16729-512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Atropine Carton)

Carton (Atropine Carton)
Atropine Sulfate Injection, USP 0.4 mg/mL (8 mg per 20 mL) multiple dose vial packaging label by Accord Healthcare Inc. The label states the solution for intravenous, intramuscular, subcutaneous, intraosseous, or endotracheal use. Storage instructions specify 20°C to 25°C, and the product is manufactured by Accord Healthcare Inc., Durham, NC, and Intas Pharmaceuticals Limited, India.*
FDA Label Image

Carton (Atropine Label)

Carton (Atropine Label)
Label for Atropine Sulfate Injection, USP 0.4 mg/mL solution in a 20 mL multiple dose vial by Accord Healthcare Inc. The label indicates an 8 mg total dose per 20 mL, with routes including intravenous, intramuscular, subcutaneous, intraosseous, and endotracheal. It lists ingredients, storage conditions, manufacturer, and includes barcode and lot/expiration date space.*
FDA Label Image

Structure (Atropine Structure)

Structure (Atropine Structure)
Chemical structure of Atropine Sulfate, showing the molecular arrangement including the tropane ring and associated functional groups, along with the sulfate and water components indicated as H2SO4 and H2O.*
FDA Label Image

Label (Atropine Ten Vials Carton Label)

Label (Atropine Ten Vials Carton Label)
The label for Atropine Sulfate Injection USP by Accord Healthcare Inc. shows a strength of 0.4 mg/mL (8 mg per 20 mL) in multiple dose vials. It indicates use routes including intravenous, intramuscular, subcutaneous, intraosseous, and endotracheal. The label includes storage instructions, manufacturer details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.